Follow-on offering Announced

Liminatus Pharma equity raising

US$4m raised

Announced 17 Feb 2026 · NASDAQ: LIMN

Advisers

Liminatus Pharma

Issuer

Legal adviser
Loeb & Loeb (as Loeb and Loeb LLP)

Lead managers

Legal adviser
Placement agent
Issuer
Liminatus Pharma
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Cell Therapy, Oncology

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.